Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Hoffmann-La Roche
Scientific Title
A Phase IB Combination Study of Rucaparib (CO-338) and Atezolizumab (MPDL3280A) in Participants With Solid Tumors and Advanced Gynecologic Cancers, With a Focus on Ovarian Cancer